BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9828831)

  • 1. Regulation of the Wilms' tumour suppressor (WT1) gene by an antisense RNA: a link with genomic imprinting?
    Ward A; Dutton JR
    J Pathol; 1998 Aug; 185(4):342-4. PubMed ID: 9828831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an antisense WT1 promoter in intron 1: implications for WT1 gene regulation.
    Malik KT; Wallace JI; Ivins SM; Brown KW
    Oncogene; 1995 Oct; 11(8):1589-95. PubMed ID: 7478583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
    Xu YQ; Grundy P; Polychronakos C
    Oncogene; 1997 Mar; 14(9):1041-6. PubMed ID: 9070652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.
    Dallosso AR; Hancock AL; Brown KW; Williams AC; Jackson S; Malik K
    Hum Mol Genet; 2004 Feb; 13(4):405-15. PubMed ID: 14681303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The imprinted antisense RNA at the Igf2r locus overlaps but does not imprint Mas1.
    Lyle R; Watanabe D; te Vruchte D; Lerchner W; Smrzka OW; Wutz A; Schageman J; Hahner L; Davies C; Barlow DP
    Nat Genet; 2000 May; 25(1):19-21. PubMed ID: 10802648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
    Vu TH; Chuyen NV; Li T; Hoffman AR
    Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro.
    Moorwood K; Charles AK; Salpekar A; Wallace JI; Brown KW; Malik K
    J Pathol; 1998 Aug; 185(4):352-9. PubMed ID: 9828833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imprinted expression of the canine IGF2R, in the absence of an anti-sense transcript or promoter methylation.
    O'Sullivan FM; Murphy SK; Simel LR; McCann A; Callanan JJ; Nolan CM
    Evol Dev; 2007; 9(6):579-89. PubMed ID: 17976054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imprinting of the murine MAS protooncogene is restricted to its antisense RNA.
    Alenina N; Bader M; Walther T
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1072-8. PubMed ID: 11798184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
    Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
    Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron-specific relaxation of Igf2r imprinting is associated with neuron-specific histone modifications and lack of its antisense transcript Air.
    Yamasaki Y; Kayashima T; Soejima H; Kinoshita A; Yoshiura K; Matsumoto N; Ohta T; Urano T; Masuzaki H; Ishimaru T; Mukai T; Niikawa N; Kishino T
    Hum Mol Genet; 2005 Sep; 14(17):2511-20. PubMed ID: 16037066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional action of the Igf2r imprint control element on upstream and downstream imprinted genes.
    Zwart R; Sleutels F; Wutz A; Schinkel AH; Barlow DP
    Genes Dev; 2001 Sep; 15(18):2361-6. PubMed ID: 11562346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic IGF2R repression does not correlate with expression of antisense RNA in human extraembryonic tissues.
    Oudejans CB; Westerman B; Wouters D; Gooyer S; Leegwater PA; van Wijk IJ; Sleutels F
    Genomics; 2001 May; 73(3):331-7. PubMed ID: 11350125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
    J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor.
    Gupta S; Joshi K; Wig JD; Arora SK
    Indian J Cancer; 2009; 46(4):303-10. PubMed ID: 19749460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo methylation at intronic CpG islands of Igf2r is associated with decreased expression of antisense RNA in aged mice.
    Yang IC; Yang SK; Park CW; Chung JH
    Biochem Biophys Res Commun; 2000 Aug; 274(3):722-6. PubMed ID: 10924343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
    Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of reciprocal genomic imprinting of sense and antisense RNA of mouse insulin-like growth factor II receptor in the central nervous system.
    Hu JF; Balaguru KA; Ivaturi RD; Oruganti H; Li T; Nguyen BT; Vu TH; Hoffman AR
    Biochem Biophys Res Commun; 1999 Apr; 257(2):604-8. PubMed ID: 10198258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.